Seasonal influenza virus vaccine quadrivalent (Sanofi Pasteur)

N/A

Report date: 2026/05/25 20:02:40

Base Information

Drug NameSeasonal influenza virus vaccine quadrivalent (Sanofi Pasteur)
Drug Alias Name四价流感病毒裂解疫苗(赛诺菲)Quadrivalent influenza vaccineShenzhen quadrivalent influenza vaccineHigh-Dose Influenza Vaccine QuadrivalentQuadrivalent inactivated influenza virus vaccine +[16] 
ClassificationVaccines > Development/production technology > Inactivated vaccine > Split vaccineVaccines > Biological material > Viral vaccineVaccines > Application > Prophylactic vaccine +[6] 
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsTriple Negative Breast NeoplasmsBreast NeoplasmsInfluenza, Human +[4] 
Global Approved IndicationsInfluenza, Human
Approved Indications in ChinaInfluenza, Human
Original Approved Country/TerritoryUnited States
Original Approved Date2013/05/28
Country/TerritoryUnited StatesVietnamMexico +[7] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesSanofi Pasteur IncSanofi PasteurSanofi Kk +[4] 
Inactive CompaniesRush University Medical CenterVanderbilt University Medical Center
Active IndicationsInfluenza, Human
Inactive IndicationsTriple Negative Breast NeoplasmsBreast NeoplasmsInfections

Other Information

ATC CodeN/A
Related LinksN/A